HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A comparative study of floctafenine (Idarac) and ibuprofen in the treatment of osteoarthrosis.

Abstract
A two-by-two-week crossover trial was conducted in patients with osteoarthrosis, using a double-dummy technique of drug administration. The drugs used were floctafenine (Idarac) and ibuprofen both given in a dose of 200 mg four times daily. Both drugs provided comparable relief of pain. Side-effects were few and generally mild. The results indicate that in the treatment of osteoarthrosis, floctafenine is comparable to ibuprofen (in the dose used in the study) in terms of efficacy and toxicity.
AuthorsV M Rhind, P A Leatham, V Wright, F A Akbar, W W Downie
JournalThe Journal of international medical research (J Int Med Res) Vol. 6 Issue 1 Pg. 11-3 ( 1978) ISSN: 0300-0605 [Print] England
PMID627302 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Quinolines
  • Ibuprofen
Topics
  • Aged
  • Female
  • Humans
  • Ibuprofen (adverse effects, therapeutic use)
  • Male
  • Middle Aged
  • Osteoarthritis (drug therapy)
  • Quinolines (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: